Arcutis Biotherapeutics (ARQT) Free Cash Flow (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Free Cash Flow of $2.1 million for Q1 2026, up 106.72% year-over-year from $1.0 million in Q1 2025, and down 92.05% quarter-over-quarter from $26.2 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Free Cash Flow (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Free Cash Flow history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 106.72% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $26.8 million (up 123.96% YoY), while the FY2025 annual figure was -$6.3 million, up 94.38% from the prior year.
- Free Cash Flow for Q1 2026 stood at $2.1 million, down from $26.2 million in the prior quarter.
- The five-year high for Free Cash Flow was $26.2 million in Q4 2025, with the low at -$80.4 million in Q1 2023.
- The 5-year median for Free Cash Flow is -$44.0 million (2023), against an average of -$36.6 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 72.99% in 2022, then surged 3600.67% in 2025.
- Arcutis Biotherapeutics' Free Cash Flow stood at -$71.2 million in 2022, then climbed by 20.98% to -$56.2 million in 2023, then jumped by 98.67% to -$748000.0 in 2024, then soared by 3600.67% to $26.2 million in 2025, then slumped by 92.05% to $2.1 million in 2026.
- Business Quant data shows ARQT's Free Cash Flow at $2.1 million in Q1 2026, $26.2 million in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.64 Mn |
| Jun 30, 2026 | 12.64 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 26.19 Mn |
| Dec 31, 2025 | 26.19 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 246,000.00 |
| Mar 31, 2025 | -30.99 Mn |
| Mar 31, 2025 | -30.99 Mn |
| Dec 31, 2024 | -748,000.00 |
| Dec 31, 2024 | -748,000.00 |
| Sep 30, 2024 | -34.83 Mn |
| Sep 30, 2024 | -34.83 Mn |
| Jun 30, 2024 | -45.12 Mn |
| Jun 30, 2024 | -45.12 Mn |
| Mar 31, 2024 | -31.60 Mn |
| Mar 31, 2024 | -31.60 Mn |